Summary: Circadian (8/24 hours) variations in serum nitric oxide (NO), total tissue factor pathway inhibitor (T-TFPI), and E-selectin levels were studied in healthy adults and in subjects with type II diabetes. We postulated a possibility a functional relationship between them because vascular endothelium is the primary site of their synthesis and functions. NO is released by the action of eNO synthase isoform and modulates physiologic responses (e.g., vascular dilation, relaxation, increasing blood flow, inhibition of platelet and white blood cell adhesion); T-TFPI, a coagulation inhibitor, is also released from endothelial cells, and is bound to plasma lipoproteins and to glycosaminoglycans; E-selectin is expressed on endothelial cells after activation by inflammatory cytokines (interleukin-1&beta; and tumor necrosis factor-&alpha;) and elevated levels (1) (2) (3) (4) (5) (6) (7) (8) (9) . NO reacts with superoxide anion radicals to form peroxynitfite, a species that can damage cells and that has been implicated in a variety of neurodegenerative disorders, inflammation, and cardiovascular events (10) (11) (12) (13) (14) .
Total tissue factor pathway inhibitor (T-TFPI) is a circulating coagulation inhibitor mostly bound to lipoproteins that are generally abnormal in diabetic subjects (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) .
The aim of the current study was to assess the circadian relationship between circulating NO, T-TFPI, and E-selectin in healthy subjects and in subjects with type II diabetes. (27, 28) . In particular, circadian characteristics for each variable and for each group of men were assessed by population multiple-component analysis (29) .
The method produces estimates of the rhythmadjusted time series mean (Fig. I ) .
Similar data for T-TFPI are presented in Table 3 and , graphically illustrated in Figure 2 . The average values for . healthy and diabetic subjects were similar, 48 ± 8 versus 49 * 7 ng/mL, and the ROC varied from 20 to 237% and from 11 1 to 100%. The times of peak concentrations were also similar, occurring in the early morning hours, 6:48 . AM. and 7:18 AM. Circadian characteristics were £lso essentially similar and no rhythm evident in either group (Fig. 2) .
E-selectin data for both groups of subjects are presented in Table 4 and illustrated in Figure 3 . The mean values for diabetic subjects were threefold greater than for healthy subjects, 81 1 * 24 versus 25 ± 16 ng/mL. The ROC from lowest to highest values, however, were lower in diabetic subjects than in healthy subjects, ranging from 53 to 31 ~~o and from 50 to 2,500%. The times of peak values were also different, occurring at 9:06 AM for diabetic and at 6:31 PM for healthy subjects (Fig. 3) Approximately 8~°I~ of T-TFPI (a thromboplastin inhibitor) circulates bound to plasma lipoproteins (15) (16) (17) 19) and only a portion of it remains bound to the endothelial surface (22) . Previous To gain some insight into the possible source of NO elevation in diabetic men, (Fig. 1) , we-have assessed some evidence for vascular endothelial cell stimulation in our subjects. E-selectin is an adhesion molecule expressed by vascular endothelial cells and is increased after stimulation by inflammatory cytokines (23) (24) (25) . It is increased in diabetic subjects and in subjects with multiple scl~;rasis ~ 1 ~. The E-selectin levels were greater in diabetic than in healthy subjects, 83 versus 26 ng/mL (Fig. 3) . This indicates that such an increase may be due to increased stimulation of the vascular endothelial cells by simple shear of increased blood pressure or by in-flammatory cytc~ki~es, or both (24) . The of NO at 6:32 PM (Fig. 1) and of E-selectin at 9:36 AM (Fig.  3 ) appear reciprocal and strongly suggest the presence off functional relationship between them in diabetic subjects. Such a relationship is not evident in healthy subjects (Figs.1 and 3) . This implies that greater endothe--lial stimulation, a greater release of NO, and elevated levels of E-selectin could be used as a marker of possible vascular damage in diabetic subjects. It may be conjectured that the higher concentration of NO, unbalanced by an increase in E-selectin, may result in increased vessel wall uptake of lipoproteins in diabetic subjects who are at greater risk than healthy men for developing diffuse atherosclerosis.
It is hoped that the current data and observations will encourage additional and expanded studies of temporal relationships between NO and T-TFPI and between NO and E-selectin. Such results could provide additional evidence for the role of NO in the vascular functions in diabetic subjects and in healthy and aging subjects.
